Trademark: 87372092
Status Date
Thursday, August 2, 2018
Filing Date
Wednesday, March 15, 2017
Published for Opposition
Tuesday, December 26, 2017
Abandoned Date
Thursday, August 2, 2018
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of overactive bladder; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations used in connection with and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; dermatological formulations, namely, medicated cleansers, medicated dry skin lotions, gels and creams, medicated skin lighteners and acne medications; none of the foregoing relating to pharmaceuticals for use in oncology
The word "ONTREZZA" has no meaning in a foreign language.
Aug 3, 2018
Abandonment Notice Mailed - Inter Partes Decision
Aug 2, 2018
Abandonment - After Inter Partes Decision
Aug 2, 2018
Opposition Terminated No. 999999
Aug 2, 2018
Opposition Dismissed No. 999999
Mar 21, 2018
Opposition Instituted No. 999999
Jan 25, 2018
Extension Of Time To Oppose Received
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Nov 21, 2017
Approved For Pub - Principal Register
Nov 20, 2017
Teas/Email Correspondence Entered
Nov 20, 2017
Correspondence Received In Law Office
Nov 15, 2017
Assigned To Lie
Nov 3, 2017
Teas Response To Office Action Received
May 12, 2017
Notification Of Examiner's Amendment/Priority Action E-Mailed
May 12, 2017
Examiner's Amendment/Priority Action E-Mailed
May 12, 2017
Combined Examiner's Amendment/Priority Action Automatic Entry
May 12, 2017
Examiners Amendment And/Or Priority Action - Completed
May 9, 2017
Assigned To Examiner
Mar 21, 2017
New Application Office Supplied Data Entered In Tram
Mar 18, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
